A new study is drawing attention to the possibility that opioid dependence may be linked to a complex molecular remodeling of the brain that involves inflammation, neuronal signaling, genetic susceptibility, and age-related changes in gene activity. Published in Aging, the research combines transcriptomic profiling, a gene-expression-based aging clock, and genome-wide association study data to investigate why chronic opioid exposure can produce persistent biological effects. Rather than showing a simple pattern in which opioid dependence uniformly accelerates biological aging, the findings suggest that age-related molecular changes may be nonlinear and differ substantially between younger and older individuals.

The study was led by Hai Duc Nguyen of the Division of Microbiology at Tulane National Biomedical Research Center and Tulane University, with Woong-Ki Kim serving as corresponding author. The researchers analyzed a publicly available brain RNA-sequencing dataset containing 42 samples: 21 from healthy controls and 21 from individuals with opioid dependence. RNA sequencing measures the abundance of messenger RNA molecules, providing a snapshot of which genes are active in a tissue. Although the dataset was relatively small, the analysis identified a distinct transcriptional signature associated with opioid dependence and offered clues about how chronic opioid exposure may affect immune and neural systems in the brain.

The initial comparison between opioid-dependent individuals and healthy controls identified 161 differentially expressed genes, including 147 genes with increased activity and 14 with reduced activity. Network analysis, which examines how genes interact and cluster within biological pathways, highlighted eight potential hub genes: CCL2, CD44, THBS1, TIMP1, CD163, IL6, IL1B, and MYC. These genes are not all involved in the same biological function, but many are connected to inflammation, immune-cell activation, tissue remodeling, and cellular stress. The concentration of these signals suggests that opioid dependence may involve coordinated changes rather than isolated shifts in individual genes.

Pathway analysis further linked the altered gene-expression profile to tumor necrosis factor signaling, cytokine activity, and inflammatory responses. Cytokines are signaling proteins that allow immune cells and other cells to communicate, while tumor necrosis factor is a major regulator of inflammation. Several of the highlighted genes are particularly relevant to neuroimmune biology. CCL2, IL6, and IL1B can participate in inflammatory signaling and microglial activation, whereas CD163 and CD44 are associated with immune-cell states, migration, and tissue responses. Microglia, the resident immune cells of the central nervous system, can influence synaptic function and neuronal survival when chronically activated. The study therefore supports a growing view that opioid dependence is shaped not only by neuronal reward circuits but also by persistent interactions between brain cells and immune pathways.

The researchers then examined whether gene-expression patterns varied with age. Participants with opioid dependence were separated into younger and older groups, revealing differences in specific genes. Expression of FAM174B, which has been associated with cellular homeostasis, was significantly lower in older individuals with opioid dependence. In contrast, ZNF256, a gene involved in transcriptional regulation, was significantly higher in younger individuals compared with healthy controls. These results indicate that the molecular profile of opioid dependence may not remain constant across adulthood. Instead, the effects observed in brain tissue could depend on a person’s age, the duration of opioid exposure, the composition of different cell types within the tissue, or interactions between aging-related and addiction-related biological processes.

To explore these interactions, the team developed a transcriptomic aging clock, an algorithm that estimates chronological age from patterns of gene expression. The researchers trained an elastic net regression model using only the 21 healthy control samples, reducing the risk that disease-associated signals would be built directly into the age-prediction model. When applied to the full dataset, the clock produced a moderate correlation between predicted and chronological age, with a correlation coefficient of 0.686 and a mean absolute error of 5.16 years. The analysis of residuals—the difference between predicted age and actual age—revealed a striking pattern. Younger individuals with opioid dependence had average positive residuals of 14.6 years, while older individuals had average negative residuals of 7.2 years.

At first glance, this pattern might appear to suggest accelerated aging in younger people and reversed aging in older people with opioid dependence. The researchers warn against such a straightforward interpretation. A transcriptomic aging clock does not directly measure biological age; it detects whether gene-expression patterns resemble those typically found in older or younger samples. Opioid dependence may alter those patterns in a way that interacts with age, producing nonlinear remodeling rather than a consistent shift in one direction. Differences in age matching, cell-type composition, clinical history, and postmortem factors could also influence the results. Two genes, PHYH and the long noncoding RNA LUCAT1, were especially associated with these age-related transcriptional states. PHYH is involved in lipid metabolism, while LUCAT1 has been linked to inflammatory regulation, making both candidates for future investigation rather than established biomarkers.

The study also examined inherited genetic risk by integrating results from six previously published GWAS, together representing 362,176 participants, including 27,024 cases and 334,972 controls. GWAS identify genetic variants that occur more frequently in people with a particular condition, although an association does not by itself prove that a variant causes disease. The analysis identified 223 unique SNP associations, with 13 reaching the conventional threshold for genome-wide significance. The strongest signal came from rs2366929 within ADGRV1, a gene connected to neurological function. Another prominent association involved OPRM1, which encodes the mu-opioid receptor targeted by opioid drugs. Additional significant loci included variants associated with CNIH3, RGMA, GPRIN3, GAPDHP15, SRP72P1, and CTCF-DT. Together, these results connect opioid dependence to genes involved in neural signaling, synaptic biology, and receptor-related mechanisms.

The combined findings present opioid dependence as a disorder in which immune activity, neuronal communication, genetic vulnerability, and age-related transcriptional regulation may converge. However, the study does not establish that opioid exposure causes the observed gene-expression changes or that the identified genes can predict who will develop dependence. The sample size was small, the control group was older on average than the younger opioid-dependent group, and the RNA sequencing was performed on bulk brain tissue rather than isolated cell populations. Information about opioid exposure history, polysubstance use, smoking, medications, psychiatric and medical conditions, and postmortem interval was not uniformly available. The aging clock was also trained against chronological age rather than an independent measure of biological aging. Larger, age-matched studies using single-cell or spatial transcriptomics, longitudinal samples, and validated biological-aging measures will be needed to determine whether these molecular patterns contribute to addiction susceptibility, disease progression, or long-term neurological consequences.

Subject of Research: Opioid dependence, brain transcriptomics, molecular aging, and genetic susceptibility

Article Title: Transcriptomic aging clock analysis identifies key genes in opioid dependence

News Publication Date: 12-Aug-2026

Web References: https://doi.org/10.18632/aging.206405; Figure 4

References: Nguyen HD et al., Aging, Volume 18, published 27-Jul-2026, DOI: 10.18632/aging.206405

Image Credits: Copyright © 2026 Nguyen et al.; distributed under the Creative Commons Attribution License (CC BY 4.0)

Keywords: Opioids, opioid dependence, transcriptomics, transcriptomic aging clock, GWAS, genetics, neuroinflammation, brain aging, cytokines, molecular biology

Tags: age-related gene activitybiological impacts of chronic opioid exposurebrain gene expressiongenetic susceptibility to addictioninflammation in opioid usemolecular remodeling in brain agingmolecular signatures of agingneuronal signaling changesnonlinear aging effectsopioid dependenceRNA sequencing in addiction researchtranscriptomic aging clock